TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in percent time <54 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient reported tolerability of dietary intervention, Likert scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of products successfully manufactured meeting the established release criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of Dose Limited Toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of Maximum Toxicity Dose
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Childhood Asthma Control Test (cACT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage Change in Immunoglobulin G (IgG) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Motor Block Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of H PYLORI Infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in reticulocyte levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Soft tissue cephalometric changes (angle)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue cephalometric changes (degrees)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver Stiffness Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Motor Unit Action Potential Amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor Unit Coherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients who initiate HCV treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number and incidence of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes of physical examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in serum level of 25 (OH) D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of conditioned hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrollment and consent rate of eligible patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Capture rate of wave form data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion rate of participant clinical data entry
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Differences in participant reported satiety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: body fat weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: skeletal body muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: physical efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of biliary stone disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Success rate of the direct pulp capping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Posttraumatic Safety Behavior Questionnaire (PSBQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Physical Activity ability measured by 6-minute walking distance measurement (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Overall respiratory relief measured by the Post-COVID-19 Functional Status (PCFS) Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cognitive impairment improvement measured by the well-validated neuropsychological measurement tests
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Freedom from hemocompatibility related adverse events (HRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Re-administration rate of sugammadex
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in shoulder joint abduction range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in shoulder joint flexion range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in elbow joint flexion range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in elbow joint extension range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in wrist joint extension range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Jobsatisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Commitment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Thoracic kyphosis index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Percentage of subjects achieving EASI-75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Biomechanical Gait Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Instrumented Timed Up and Go (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of mortality
Endpoint domain: Mortality/survival
Primary endpoint: Progression to severe dengue
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free survival rate at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Arterial pH level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in modified Toronto Clinical Neuropathy Score (mTCNS)- Sensory Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of paraaortic lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Fungal infection status in nail clippings measured by microscopy
Endpoint domain: Adverse events/effects
Primary endpoint: Fungal infection status in nail clippings measured by culture
Endpoint domain: Adverse events/effects
Primary endpoint: Mean time to complete venous access
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: arterial thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: Child Suicidal Thoughts and Behaviors
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of CLL patients who develop a new NMSC
Endpoint domain: Adverse events/effects
Primary endpoint: Time-in-target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Esophageal pressure swings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Consultation on Incontinence Questionnaire Short Form
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: No vaginal or anal sex, or use of condoms or effective birth control
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in 24-hour urine oxalate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent absorption of 13C2-oxalate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in urine 13C2-oxalate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to Radiological Fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Parkinson's Disease Quality of Life 7 Questionnaire (PDQoL7)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Positive and Negative Symptoms of Psychosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neck awareness
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maxillary arch dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Score on Wisconsin Smoking Withdrawal Scale2 Long (WSWS2-L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Wisconsin Smoking Withdrawal Scale2 Brief Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resultant Thickness of the LASIK Flap
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Thoracic and lumbar spine ranges of motions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paraspinal muscle activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum IL6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Fraction of participants reaching therapeutic exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with the Intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intentions to consume sugary drinks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of abnormal laboratory values
Endpoint domain: Adverse events/effects
Primary endpoint: Pain in at rest and at chewing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete vaginal graft attachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: circulating neutrophils level > 7000/mm3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of patients with global severity
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gray matter density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients with clinical and endoscopic remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of pediatrics with vascular thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of risk factors of pediatric vascular thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Days the activity monitor was worn
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Glomerular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in NAFLD grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-efficacy scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of ACS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scale for the assessment and rating of ataxia (SARA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: ADL (Flow-FIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient Improvement Impression
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bayley scales of infant and Toddler Development-fourth edition
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Comprehensive Development Inventory for Infant and Toddlers
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Weight-for-length (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Internal carotid blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of TBI patients who decide to enroll in a clinical research
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of TBI patients who remain in clinical trial to trial completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Gene expression and sweet taste perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gene expression and sweet taste liking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gene expression and dietary intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gene expression and sweet liker status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants recruited and rates of retention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants who attend each session
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Staff satisfaction with training
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intervention fidelity
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants who adhere to components of intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Characterize the Safety of SP-3164
Endpoint domain: Adverse events/effects
Primary endpoint: Assess Dose Limiting Toxicities of SP-3164
Endpoint domain: Adverse events/effects
Primary endpoint: Assess the Maximum Tolerated Dose of SP-3164
Endpoint domain: Adverse events/effects
Primary endpoint: User errors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability E-Scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression Free Survival rate of 1 year
Endpoint domain: Mortality/survival
Primary endpoint: Dynamic balance during gait: medio-lateral center of mass excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait kinematics: maximum knee extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Emotional Manifestation Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physiological Measurement Form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Anxiety Scale for Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PROMIS Pediatric Mobility Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: waist-to-hip ratio changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body mass index changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of Apnea Hypopnea Index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change in central retinal thickness (CRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: change in diabetic retinopathy severity score (DRSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Body weight (Percent Change)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Beck's Depression Inventory II Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients with device weight unconformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carbon-di-oxide equivalent -20 years (CDE20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wong-Baker Facial Expression Evaluation Scale (WB-FAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Fear Scale (CFS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Survival Information
Endpoint domain: Mortality/survival
Primary endpoint: Rate of ovary abscess
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of return to main sport at the expected level
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Genetic variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Self-Criticism
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Self-Compassion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: accuracy of numerical simulation to predict stent-graft apposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change of biomarkers in ARDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of biomarkers with disturbance of consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of biomarkers with abnormal coagulation function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change of biomarkers with circulatory failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of biomarkers with acute kidney failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change of biomarkers with liver failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening based on the NIAID Ordinal scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ground Reaction Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Blood pressure readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Identification rate of the correct transverse abdominis plane block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: biomarker of pulmonary vasculopathy in HF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CT characteristics of pulmonary vasculopathy in HF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CT characteristics of presence of heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Achieving clinical intent of procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidences of CMV reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of bone fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Micheli Functional Scale (MFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in edema on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to return to sport (days)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diet adherence as assessed by 3 day food records
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Statin Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: LDL Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in weekly seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Seizure severity questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Identification and prevalence of somatic mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Identification and prevalence of epigenetic modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Assessment of HPV viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Response rate of average pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection accuracy of urinary bladder invasion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of patients with CST <300 μm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-minute walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wexner Constipation Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 24-hour ambulatory diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in suicidality on the SIDAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depression on the CESD-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: life disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: frequency and severity of headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preoperative Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Richards Campbell Sleep Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep